Regeneron Pharmaceuticals
REGN
#118
Rank
โ‚ฌ113.28 B
Marketcap
1.028ย โ‚ฌ
Share price
-0.69%
Change (1 day)
33.16%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ7.11 B

According to Regeneron Pharmaceuticals's latest financial reports the company's total liabilities are โ‚ฌ7.11 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regeneron Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ6.42 B5.28%
2022-12-31โ‚ฌ6.10 B4.22%
2021-12-31โ‚ฌ5.85 B16.69%
2020-12-31โ‚ฌ5.02 B51.74%
2019-12-31โ‚ฌ3.30 B27.32%
2018-12-31โ‚ฌ2.59 B19.01%
2017-12-31โ‚ฌ2.18 B-9%
2016-12-31โ‚ฌ2.39 B34.06%
2015-12-31โ‚ฌ1.79 B69.26%
2014-12-31โ‚ฌ1.05 B46.26%
2013-12-31โ‚ฌ0.72 B14.44%
2012-12-31โ‚ฌ0.63 B-2.07%
2011-12-31โ‚ฌ0.64 B52.42%
2010-12-31โ‚ฌ0.42 B75.94%
2009-12-31โ‚ฌ0.24 B12.13%
2008-12-31โ‚ฌ0.21 B-33.55%
2007-12-31โ‚ฌ0.32 B15.62%
2006-12-31โ‚ฌ0.27 B6.88%
2005-12-31โ‚ฌ0.26 B35.95%
2004-12-31โ‚ฌ0.19 B-29.79%
2003-12-31โ‚ฌ0.27 B16.51%
2002-12-31โ‚ฌ0.23 B-9.41%
2001-12-31โ‚ฌ0.25 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ76.68 B 978.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.62 B-49.08%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.84 B 38.50%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ98.85 B 1,290.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ50.17 B 605.53%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ54.90 B 672.03%๐Ÿ‡ซ๐Ÿ‡ท France